Petros Pharmaceuticals, Inc. (PTPI) Return on equity 2020–2023
Petros Pharmaceuticals, Inc. (PTPI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.6%FY2023 · since FY2020: -117.8% → -67.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -67.6% | +52.3 pp |
| FY2022 | -120.0% | -94.7 pp |
| FY2021 | -25.3% | +92.6 pp |
| FY2020 | -117.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice